In this study, we demonstrated that a new lncRNA GPNCA located in the 3q13.33 region is upregulated in many human cancers, including colon cancer and liver cancer, both of which rank amongst the top ten human malignant tumors2, suggesting GPNCA represents a biomarker for cancer diagnosis. This evidence concerns the gene GSK3B-DT and cancer.